-
2
-
-
84938566670
-
-
Publications Office of the European Union
-
European Monitoring Centre for Drugs and Drug Addiction. European Drug Report 2014: Trends and Developments. Publications Office of the European Union. 2014. DOI: 10.2810/32306
-
(2014)
European Drug Report 2014: Trends and Developments
-
-
-
4
-
-
84879793220
-
Two new-type cannabimimetic quinolinyl carboxylates, QUPIC and QUCHIC, two new cannabimimetic carboxamide derivatives, ADB-FUBINACA and ADBICA, and five synthetic cannabinoids detected with a thiophene derivative α-PVT and an opioid receptor agonist AH-7921 identified in illegal products
-
N. Uchiyama, S. Matsuda, M. Kawamura, R. Kikura-Hanajiri, Y. Goda. Two new-type cannabimimetic quinolinyl carboxylates, QUPIC and QUCHIC, two new cannabimimetic carboxamide derivatives, ADB-FUBINACA and ADBICA, and five synthetic cannabinoids detected with a thiophene derivative α-PVT and an opioid receptor agonist AH-7921 identified in illegal products. Forensic Toxicol. 2013, 31, 223.
-
(2013)
Forensic Toxicol.
, vol.31
, pp. 223
-
-
Uchiyama, N.1
Matsuda, S.2
Kawamura, M.3
Kikura-Hanajiri, R.4
Goda, Y.5
-
5
-
-
84928172831
-
Fatal Intoxications Associated with the Designer Opioid AH-7921
-
R. Kronstrand, G. Thelander, D. Lindstedt, M. Roman, F. C. Kugelberg. Fatal Intoxications Associated with the Designer Opioid AH-7921. J. Anal. Tox. 2014, 38, 599.
-
(2014)
J. Anal. Tox.
, vol.38
, pp. 599
-
-
Kronstrand, R.1
Thelander, G.2
Lindstedt, D.3
Roman, M.4
Kugelberg, F.C.5
-
7
-
-
84911045078
-
Lethal poisonings with AH-7921 in combination with other substances
-
R. Karinen, S. S. Tuv, S. Rogde, M. D. Peres, U. Johansen, J. Frost, V. Vindenes, Å. M. L. Øiestad. Lethal poisonings with AH-7921 in combination with other substances. Forensic Sci. Int. 2014, 244, e21.
-
(2014)
Forensic Sci. Int.
, vol.244
-
-
Karinen, R.1
Tuv, S.S.2
Rogde, S.3
Peres, M.D.4
Johansen, U.5
Frost, J.6
Vindenes, V.7
Øiestad, Å.M.L.8
-
8
-
-
84898637042
-
A Fatality Involving AH-7921
-
S. P. Vorce, J. L. Knittel, J. M. Holler, J. Magluilo, B. Levine, P. Berran, T. Z. Bosy. A Fatality Involving AH-7921. J. Anal. Tox. 2014, 38, 226.
-
(2014)
J. Anal. Tox.
, vol.38
, pp. 226
-
-
Vorce, S.P.1
Knittel, J.L.2
Holler, J.M.3
Magluilo, J.4
Levine, B.5
Berran, P.6
Bosy, T.Z.7
-
10
-
-
0015709685
-
Anti-nociceptive effects in N-substituted cyclohexylmethylbenzamides
-
R. T. Brittain, D. N. Kellett, M. L. Neat, R. Stables. Anti-nociceptive effects in N-substituted cyclohexylmethylbenzamides. Br. J. Pharmacol. 1973, 49, 158P.
-
(1973)
Br. J. Pharmacol.
, vol.49
, pp. 158P
-
-
Brittain, R.T.1
Kellett, D.N.2
Neat, M.L.3
Stables, R.4
-
12
-
-
85153149216
-
-
[30 July 2015]
-
Australian Government, Department of Health. Reasons for scheduling delegates' final decisions. 2014. Available at: http://www.tga.gov.au/industry/scheduling-decisions-1405-final.htm#.U9AdU7H4IvJ [30 July 2015].
-
(2014)
Reasons for scheduling delegates' final decisions
-
-
-
13
-
-
85153150524
-
-
L 287/22, 571., [30 July 2015]
-
EU Concil. 2014/688/EU: Council Implementing Decision of 25 September 2014 on subjecting 4-iodo-2,5-dimethoxy-N-(2-methoxybenzyl)phenethylamine (25I-NBOMe), 3,4-dichloro-N-[[1-(dimethylamino)cyclohexyl]methyl]benzamide (AH-7921), 3,4-methylenedioxypyrovalerone (MDPV) and 2-(3-methoxyphenyl)-2-(ethylamino)cyclohexanone (methoxetamine) to control measures. Official Journal of the European Union. 2014. L 287/22, 571. Available at: http://eur-lex.europa.eu/legal-content/EN/TXT/?uri=uriserv:OJ.L_.2014.287.01.0022.01.ENG [30 July 2015].
-
(2014)
2014/688/EU: Council Implementing Decision of 25 September 2014 on subjecting 4-iodo-2,5-dimethoxy-N-(2-methoxybenzyl)phenethylamine (25I-NBOMe), 3,4-dichloro-N-[[1-(dimethylamino)cyclohexyl]methyl]benzamide (AH-7921), 3,4-methylenedioxypyrovalerone (MDPV) and 2-(3-methoxyphenyl)-2-(ethylamino)cyclohexanone (methoxetamine) to control measures. Official Journal of the European Union
-
-
-
14
-
-
0020620592
-
Determination of receptors that mediate opiate side effects in the mouse
-
A. G. Hayes, M. Tyers. Determination of receptors that mediate opiate side effects in the mouse. Br. J. Pharmacol. 1983, 79, 731.
-
(1983)
Br. J. Pharmacol.
, vol.79
, pp. 731
-
-
Hayes, A.G.1
Tyers, M.2
-
15
-
-
85153166697
-
-
[30 July 2015]
-
Bluelight Drug User Forum. Thread on AH-7921. 2012. Available at: http://www.bluelight.org/vb/threads/612116-The-AH-7921-%28Ah7921%29-Megathread-%28v1%29 [30 July 2015].
-
(2012)
Thread on AH-7921
-
-
-
16
-
-
85153145762
-
-
[30 July 2015]
-
ChemsRUs Drug User Forum. Thread on AH-7921. 2013. Available at: http://www.chemsrus.com/forum/14-trip-reports/9826-ah-7921-my-experience-with-this-rc-opioid [30 July 2015].
-
(2013)
Thread on AH-7921
-
-
-
17
-
-
84904559582
-
An investigation of the stability of emerging new psychoactive substances
-
Y. N. A. Soh, S. Elliott. An investigation of the stability of emerging new psychoactive substances. Drug Test. Anal. 2014, 6, 696.
-
(2014)
Drug Test. Anal.
, vol.6
, pp. 696
-
-
Soh, Y.N.A.1
Elliott, S.2
-
18
-
-
33748636018
-
Introduction to in vitro estimation of metabolic stability and drug interactions of new chemical entities in drug discovery and development
-
P. Baranczewski, A. Stanczak, K. Sundberg, R. Svensson, A. Wallin, J. Jansson, P. Garberg, H. Postlind. Introduction to in vitro estimation of metabolic stability and drug interactions of new chemical entities in drug discovery and development. Pharmacol. Rep. 2006, 58, 453.
-
(2006)
Pharmacol. Rep.
, vol.58
, pp. 453
-
-
Baranczewski, P.1
Stanczak, A.2
Sundberg, K.3
Svensson, R.4
Wallin, A.5
Jansson, J.6
Garberg, P.7
Postlind, H.8
-
19
-
-
40749151480
-
An automated liquid chromatography-mass spectrometry process to determine metabolic stability half-life and intrinsic clearance of drug candidates by substrate depletion
-
C. A. McNaney, D. M. Drexler, S. Y. Hnatyshyn, T. A. Zvyaga, J. O. Knipe, J. V. Belcastro, M. Sanders. An automated liquid chromatography-mass spectrometry process to determine metabolic stability half-life and intrinsic clearance of drug candidates by substrate depletion. ASSAY Drug Dev. Technol. 2008, 6, 121.
-
(2008)
ASSAY Drug Dev. Technol.
, vol.6
, pp. 121
-
-
McNaney, C.A.1
Drexler, D.M.2
Hnatyshyn, S.Y.3
Zvyaga, T.A.4
Knipe, J.O.5
Belcastro, J.V.6
Sanders, M.7
-
20
-
-
85153169018
-
-
[30 July 2015]
-
Molecular Discovery. Introduction on MetaSite software. 2015. Available at: http://www.moldiscovery.com/software/metasite/ [30 July 2015].
-
(2015)
Introduction on MetaSite software
-
-
-
21
-
-
0030911863
-
The use of human hepatocytes to select compounds based on their expected hepatic extraction ratios in humans
-
T. Lavé, S. Dupin, C. Schmitt, B. Valles, G. Ubeaud, R. C. Chou, D. Jaeck, P. Coassolo. The use of human hepatocytes to select compounds based on their expected hepatic extraction ratios in humans. Pharm Res. 1997, 14, 152.
-
(1997)
Pharm Res.
, vol.14
, pp. 152
-
-
Lavé, T.1
Dupin, S.2
Schmitt, C.3
Valles, B.4
Ubeaud, G.5
Chou, R.C.6
Jaeck, D.7
Coassolo, P.8
-
23
-
-
0032880131
-
Determination of morphine, morphine-3-glucuronide, and morphine-6-glucuronide in plasma after intravenous and intrathecal morphine administration using HPLC with electrospray ionization and tandem mass spectrometry
-
M. H. Slawson, D. J. Crouch, D. M. Andrenyak, D. E. Rollins, J. K. Lu, P. L. Bailey. Determination of morphine, morphine-3-glucuronide, and morphine-6-glucuronide in plasma after intravenous and intrathecal morphine administration using HPLC with electrospray ionization and tandem mass spectrometry. J. Anal. Tox. 1999, 23, 468.
-
(1999)
J. Anal. Tox.
, vol.23
, pp. 468
-
-
Slawson, M.H.1
Crouch, D.J.2
Andrenyak, D.M.3
Rollins, D.E.4
Lu, J.K.5
Bailey, P.L.6
-
24
-
-
84860422863
-
Quantitative liquid chromatographic analysis of anthracyclines in biological fluids
-
K. E. Maudens, C. P. Stove, W. E. Lambert. Quantitative liquid chromatographic analysis of anthracyclines in biological fluids. J. Chrom. B. 2011, 879, 2471.
-
(2011)
J. Chrom. B.
, vol.879
, pp. 2471
-
-
Maudens, K.E.1
Stove, C.P.2
Lambert, W.E.3
-
25
-
-
77952312729
-
Sequential metabolism of secondary alkyl amines to metabolic-intermediate complexes: opposing roles for the secondary hydroxylamine and primary amine metabolites of desipramine, (S)-fluoxetine, and N-desmethyldiltiazem
-
K. L. Hanson, B. M. VandenBrink, K. N. Babu, K. E. Allen, W. L. Nelson, K. L. Kunze. Sequential metabolism of secondary alkyl amines to metabolic-intermediate complexes: opposing roles for the secondary hydroxylamine and primary amine metabolites of desipramine, (S)-fluoxetine, and N-desmethyldiltiazem. Drug Metab. Dispos. 2010, 38, 963.
-
(2010)
Drug Metab. Dispos.
, vol.38
, pp. 963
-
-
Hanson, K.L.1
VandenBrink, B.M.2
Babu, K.N.3
Allen, K.E.4
Nelson, W.L.5
Kunze, K.L.6
-
26
-
-
81855228701
-
Biosynthesis and identification of an N-oxide/N-glucuronide metabolite and first synthesis of an N-O-glucuronide metabolite of Lu AA21004
-
H. K. Uldam, M. Juhl, H. Pedersen, L. Dalgaard. Biosynthesis and identification of an N-oxide/N-glucuronide metabolite and first synthesis of an N-O-glucuronide metabolite of Lu AA21004. Drug Metab. Dispos. 2011, 39, 2264.
-
(2011)
Drug Metab. Dispos.
, vol.39
, pp. 2264
-
-
Uldam, H.K.1
Juhl, M.2
Pedersen, H.3
Dalgaard, L.4
|